Doxorubicin Hydrochloride (Doxil)


Indications and Reactions:

Role Indications Reactions
Primary
Ovarian Cancer 12.3%
Multiple Myeloma 9.6%
Ovarian Cancer Recurrent 8.8%
Lymphoma Aids Related 8.4%
Product Used For Unknown Indication 8.2%
Plasma Cell Myeloma 6.1%
Haematological Malignancy 5.2%
Ovarian Epithelial Cancer Recurrent 4.8%
Acute Leukaemia 4.6%
Palliative Care 4.2%
Hodgkin's Disease 3.8%
Neoplasm Malignant 3.3%
Breast Cancer Metastatic 3.1%
Prophylaxis 3.1%
Foetal Exposure During Pregnancy 2.7%
Kaposi's Sarcoma Aids Related 2.5%
Non-hodgkin's Lymphoma 2.5%
Diffuse Large B-cell Lymphoma 2.3%
Mycosis Fungoides 2.3%
Cancer Pain 2.1%
Off Label Use 9.1%
Thrombocytopenia 9.1%
Vomiting 9.1%
Squamous Cell Carcinoma Of The Oral Cavity 7.3%
Cellulitis 5.5%
Neuropathy Peripheral 5.5%
Pain 5.5%
Urinary Tract Infection 5.5%
Fistula 3.6%
Haemoglobin Abnormal 3.6%
Maternal Exposure During Pregnancy 3.6%
Neutropenia 3.6%
Pneumocystis Jirovecii Pneumonia 3.6%
Pneumonia 3.6%
Progressive Multifocal Leukoencephalopathy 3.6%
Shock 3.6%
Skin Disorder 3.6%
Skin Exfoliation 3.6%
Skin Toxicity 3.6%
Squamous Cell Carcinoma Of The Tongue 3.6%
Secondary
Ovarian Cancer Recurrent 24.4%
Ovarian Epithelial Cancer Recurrent 9.7%
Multiple Myeloma 9.3%
Stomatitis 6.9%
Plasma Cell Myeloma 6.4%
Ovarian Cancer 6.0%
Product Used For Unknown Indication 5.5%
Hodgkin's Disease 4.8%
Prophylaxis 4.3%
Acute Leukaemia 4.0%
Non-hodgkin's Lymphoma 3.2%
Diffuse Large B-cell Lymphoma 2.9%
Cancer Pain 2.8%
Mycosis Fungoides 2.0%
Hypertension 1.6%
Palmar-plantar Erythrodysaesthesia Syndrome 1.6%
Squamous Cell Carcinoma 1.6%
Lymphoma Aids Related 1.3%
Ovarian Epithelial Cancer 0.9%
Constipation 0.7%
Staphylococcal Infection 19.7%
Renal Failure 8.2%
Thrombocytopenia 8.2%
Renal Failure Chronic 6.6%
Tremor 6.6%
Urinary Tract Infection 6.6%
Vomiting 6.6%
Loss Of Consciousness 4.9%
Skin Toxicity 4.9%
Cellulitis 3.3%
Maternal Exposure During Pregnancy 3.3%
Ovarian Cancer Recurrent 3.3%
Pain Of Skin 3.3%
Squamous Cell Carcinoma Of The Oral Cavity 3.3%
Stomatitis 3.3%
Neutropenia 1.6%
Pneumocystis Jirovecii Pneumonia 1.6%
Progressive Multifocal Leukoencephalopathy 1.6%
Septic Shock 1.6%
Skin Exfoliation 1.6%

Drug Data